Cancer cell plasticity during tumor progression, metastasis and response to therapy
暂无分享,去创建一个
[1] Akiyoshi Uemura,et al. RHOJ controls EMT-associated resistance to chemotherapy , 2023, Nature.
[2] Camille Stephan-Otto Attolini,et al. Metastatic recurrence in colorectal cancer arises from residual EMP1+ cells , 2022, Nature.
[3] C. Li,et al. Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment , 2022, Nature Communications.
[4] G. Hannon,et al. The NALCN channel regulates metastasis and nonmalignant cell dissemination , 2022, Nature Genetics.
[5] Y. Saeys,et al. A cellular hierarchy in melanoma uncouples growth and metastasis , 2022, Nature.
[6] E. Kenigsberg,et al. ZFP281 drives a mesenchymal-like dormancy program in early disseminated breast cancer cells that prevents metastatic outgrowth in the lung , 2022, Nature Cancer.
[7] Tao Wang,et al. Ectopic JAK–STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance , 2022, Nature Cancer.
[8] L. Mazutis,et al. Lineage plasticity in prostate cancer depends on JAK/STAT inflammatory signaling , 2022, Science.
[9] P. Wirapati,et al. Dynamic and adaptive cancer stem cell population admixture in colorectal neoplasia , 2022, Cell stem cell.
[10] Takeshi Imamura,et al. Cell–matrix interface regulates dormancy in human colon cancer stem cells , 2022, Nature.
[11] G. Stassi,et al. Mex3a marks drug-tolerant persister colorectal cancer cells that mediate relapse after chemotherapy , 2022, Nature Cancer.
[12] S. Dietmann,et al. Mitochondrial RNA modifications shape metabolic plasticity in metastasis , 2022, Nature.
[13] Stephen M. Douglass,et al. Stromal changes in the aged lung induce an emergence from melanoma dormancy , 2022, Nature.
[14] M. Salido,et al. p53 wild-type colorectal cancer cells that express a fetal gene signature are associated with metastasis and poor prognosis , 2022, Nature Communications.
[15] P. Carmeliet,et al. PHGDH heterogeneity potentiates cancer cell dissemination and metastasis , 2022, Nature.
[16] M. Stratton,et al. Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors , 2022, Nature Cancer.
[17] Kongming Wu,et al. Notch signaling pathway: architecture, disease, and therapeutics , 2022, Signal Transduction and Targeted Therapy.
[18] P. Saw,et al. Targeting CAFs to overcome anticancer therapeutic resistance. , 2022, Trends in cancer.
[19] F. Buettner,et al. Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer. , 2022, Cancer cell.
[20] S. Horswell,et al. Radiation exposure elicits a neutrophil-driven response in healthy lung tissue that enhances metastatic colonization , 2022, Nature Cancer.
[21] Catherine J. Wu,et al. Natural Barcodes for Longitudinal Single Cell Tracking of Leukemic and Immune Cell Dynamics , 2022, Frontiers in Immunology.
[22] G. Christofori,et al. Distinct contributions of partial and full EMT to breast cancer malignancy. , 2021, Developmental cell.
[23] Sendurai A Mani,et al. Epithelial-to-Mesenchymal Plasticity in Circulating Tumor Cell Lines Sequentially Derived from a Patient with Colorectal Cancer , 2021, Cancers.
[24] Stephanie Ma,et al. The Role of Cancer-Associated Fibroblast as a Dynamic Player in Mediating Cancer Stemness in the Tumor Microenvironment , 2021, Frontiers in Cell and Developmental Biology.
[25] Hongmei Zhou,et al. Cancer-Associated Fibroblasts Facilitate Squamous Cell Carcinoma Lung Metastasis in Mice by Providing TGFβ-Mediated Cancer Stem Cell Niche , 2021, Frontiers in Cell and Developmental Biology.
[26] A. Regev,et al. Cycling cancer persister cells arise from lineages with distinct programs , 2021, Nature.
[27] Howard Y. Chang,et al. LKB1 inactivation modulates chromatin accessibility to drive metastatic progression , 2021, Nature Cell Biology.
[28] E. Fertig,et al. A tumor-derived type III collagen-rich ECM niche regulates tumor cell dormancy , 2021, Nature Cancer.
[29] E. Kenigsberg,et al. Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cells , 2021, Nature.
[30] R. Kalluri,et al. αSMA+ fibroblasts suppress Lgr5+ cancer stem cells and restrain colorectal cancer progression , 2021, Oncogene.
[31] D. Lambrechts,et al. Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma. , 2021, Cancer cell.
[32] D. Chan,et al. The Impact of the Tumor Microenvironment on Macrophage Polarization in Cancer Metastatic Progression , 2021, International journal of molecular sciences.
[33] Beth K. Martin,et al. Single-cell lineage tracing of metastatic cancer reveals selection of hybrid EMT states. , 2021, Cancer cell.
[34] A. Regev,et al. Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma. , 2021, Cancer cell.
[35] J. Visvader,et al. A single‐cell RNA expression atlas of normal, preneoplastic and tumorigenic states in the human breast , 2021, The EMBO journal.
[36] K. Tomczak,et al. Identification of EMT signaling cross-talk and gene regulatory networks by single-cell RNA sequencing , 2021, Proceedings of the National Academy of Sciences.
[37] A. Trumpp,et al. Perivascular tenascin C triggers sequential activation of macrophages and endothelial cells to generate a pro-metastatic vascular niche in the lungs , 2021, Nature Cancer.
[38] F. Lemonnier,et al. BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemia. , 2021, Blood.
[39] D. Pe’er,et al. A gene-environment induced epigenetic program initiates tumorigenesis , 2021, Nature.
[40] G. Bergers,et al. The metabolism of cancer cells during metastasis , 2021, Nature Reviews Cancer.
[41] Jordan G Bryan,et al. An Embryonic Diapause-like Adaptation with Suppressed Myc Activity Enables Tumor Treatment Persistence. , 2021, Cancer cell.
[42] Z. Zeng,et al. Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments , 2021, Molecular cancer.
[43] Trevor J Pugh,et al. Colorectal Cancer Cells Enter a Diapause-like DTP State to Survive Chemotherapy , 2021, Cell.
[44] J. Massagué,et al. Targeting metastatic cancer , 2021, Nature Medicine.
[45] K. Mortezaee,et al. Steps in metastasis: an updated review , 2021, Medical Oncology.
[46] Yi-Wen Chang,et al. STAT3 phosphorylation at Ser727 and Tyr705 differentially regulates the EMT–MET switch and cancer metastasis , 2020, Oncogene.
[47] X. Zhang,et al. The bone microenvironment invigorates metastatic seeds for further dissemination , 2020, Cell.
[48] Soon Sung Kwon,et al. Cancer-initiating cells in human pancreatic cancer organoids are maintained by interactions with endothelial cells. , 2020, Cancer letters.
[49] S. Shen,et al. Persistent Cancer Cells: The Deadly Survivors , 2020, Cell.
[50] Shivashankar H. Nagaraj,et al. Limiting Self-Renewal of the Basal Compartment by PKA Activation Induces Differentiation and Alters the Evolution of Mammary Tumors. , 2020, Developmental cell.
[51] L. Geris,et al. Tumor exposed-lymphatic endothelial cells promote primary tumor growth via IL6 , 2020, Cancer letters.
[52] Wei Sun,et al. Jagged1-Notch1-deployed tumor perivascular niche promotes breast cancer stem cell phenotype through Zeb1 , 2020, Nature Communications.
[53] S. Dawson,et al. Non-genetic mechanisms of therapeutic resistance in cancer , 2020, Nature Reviews Cancer.
[54] K. Mechtler,et al. LSD1 inhibition induces differentiation and cell death in Merkel cell carcinoma , 2020, EMBO molecular medicine.
[55] C. Klein. Cancer progression and the invisible phase of metastatic colonization , 2020, Nature Reviews Cancer.
[56] A. Rustgi,et al. EMT, MET, Plasticity, and Tumor Metastasis. , 2020, Trends in cell biology.
[57] Erin L. Schenk,et al. Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing , 2020, Cell.
[58] I. Spiteri,et al. Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell–like phenotype , 2020, Science Translational Medicine.
[59] T. Voet,et al. Heterotypic cell–cell communication regulates glandular stem cell multipotency , 2020, Nature.
[60] S. Aerts,et al. Robust gene expression programs underlie recurrent cell states and phenotype switching in melanoma , 2020, Nature Cell Biology.
[61] R. Hass. Role of MSC in the Tumor Microenvironment , 2020, Cancers.
[62] F. Camargo,et al. Regenerative Reprogramming of the Intestinal Stem Cell State via Hippo Signaling Suppresses Metastatic Colorectal Cancer. , 2020, Cell stem cell.
[63] R. Derynck,et al. TGFβ biology in cancer progression and immunotherapy , 2020, Nature Reviews Clinical Oncology.
[64] S. Morrison,et al. Lymph protects metastasizing melanoma cells from ferroptosis , 2020, Nature.
[65] A. Regev,et al. Emergence of a High-Plasticity Cell State during Lung Cancer Evolution. , 2020, Cancer cell.
[66] Kevin Petrecca,et al. Single-cell RNA-seq reveals that glioblastoma recapitulates a normal neurodevelopmental hierarchy , 2020, Nature Communications.
[67] Kathy O. Lui,et al. Genetic Fate Mapping of Transient Cell Fate Reveals N-Cadherin Activity and Function in Tumor Metastasis. , 2020, Developmental cell.
[68] Albert C. Chen,et al. Matrix Rigidity Controls Epithelial-Mesenchymal Plasticity and Tumor Metastasis via a Mechanoresponsive EPHA2/LYN Complex. , 2020, Developmental cell.
[69] R. Piñeiro,et al. Analysis of a Real-World Cohort of Metastatic Breast Cancer Patients Shows Circulating Tumor Cell Clusters (CTC-clusters) as Predictors of Patient Outcomes , 2020, Cancers.
[70] B. Faubert,et al. Metabolic reprogramming and cancer progression , 2020, Science.
[71] A. Regev,et al. Transcriptional mediators of treatment resistance in lethal prostate cancer , 2020, Nature Medicine.
[72] F. Castro-Giner,et al. Tracking cancer progression: from circulating tumor cells to metastasis , 2020, Genome Medicine.
[73] A. Sieuwerts,et al. Plasticity of Lgr5-Negative Cancer Cells Drives Metastasis in Colorectal Cancer , 2020, Cell stem cell.
[74] Z. Zeng,et al. Single cell RNA-seq reveals the landscape of tumor and infiltrating immune cells in nasopharyngeal cancer. , 2020, Cancer letters.
[75] N. Birkbak,et al. Cancer Genome Evolutionary Trajectories in Metastasis. , 2020, Cancer cell.
[76] Ashley M. Laughney,et al. L1CAM defines the regenerative origin of metastasis-initiating cells in colorectal cancer , 2020, Nature Cancer.
[77] V. De Maertelaer,et al. Context Dependency of Epithelial-to-Mesenchymal Transition for Metastasis. , 2019, Cell reports.
[78] D. Schadendorf,et al. Metabolic heterogeneity confers differences in melanoma metastatic potential , 2019, Nature.
[79] C. Blanpain,et al. Spatiotemporal regulation of multipotency during prostate development , 2019, Development.
[80] K. Vousden,et al. Cell Clustering Promotes a Metabolic Switch that Supports Metastatic Colonization , 2019, Cell metabolism.
[81] S. Kletukhina,et al. Role of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Epithelial–Mesenchymal Transition , 2019, International journal of molecular sciences.
[82] J. Mills,et al. Nomenclature for cellular plasticity: are the terms as plastic as the cells themselves? , 2019, The EMBO journal.
[83] Joel S. Bader,et al. E-cadherin is required for metastasis in multiple models of breast cancer , 2019, Nature.
[84] Mariella G. Filbin,et al. An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma , 2019, Cell.
[85] K. Polyak,et al. Intratumoral Heterogeneity: More Than Just Mutations. , 2019, Trends in cell biology.
[86] N. Nishimura,et al. Endothelial cells promote 3D invasion of GBM by IL-8-dependent induction of cancer stem cell properties , 2019, Scientific Reports.
[87] E. Fuchs,et al. Adaptive Immune Resistance Emerges from Tumor-Initiating Stem Cells , 2019, Cell.
[88] Sydney M. Shaffer,et al. Genetic screening for single-cell variability modulators driving therapy resistance , 2019, bioRxiv.
[89] Kin F. Chan,et al. Single-cell transcriptomes of the regenerating intestine reveal a revival stem cell , 2019, Nature.
[90] Shuyi Wang,et al. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis , 2019, Molecular Cancer.
[91] R. Weinberg,et al. Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells , 2019, Proceedings of the National Academy of Sciences.
[92] Yibin Kang,et al. Bone Vascular Niche E-selectin Induces Mesenchymal-Epithelial Transition and Wnt Activation in Cancer Cells to Promote Bone Metastasis , 2019, Nature Cell Biology.
[93] Martin J. Aryee,et al. Lineage Tracing in Humans Enabled by Mitochondrial Mutations and Single-Cell Genomics , 2019, Cell.
[94] C. Blanpain,et al. EMT Transition States during Tumor Progression and Metastasis. , 2019, Trends in cell biology.
[95] C. Verfaillie,et al. Breast cancer cells rely on environmental pyruvate to shape the metastatic niche , 2019, Nature.
[96] N. Beerenwinkel,et al. Neutrophils escort circulating tumour cells to enable cell cycle progression , 2019, Nature.
[97] Z. Zeng,et al. Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape , 2019, Molecular Cancer.
[98] J. Rich,et al. Cancer Stem Cells: The Architects of the Tumor Ecosystem. , 2019, Cell stem cell.
[99] T. Brabletz,et al. Non-redundant functions of EMT transcription factors , 2019, Nature Cell Biology.
[100] Piyush B. Gupta,et al. Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance. , 2019, Cell stem cell.
[101] Xiaohui Zhu,et al. Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis , 2018, Nature Communications.
[102] J. Tabernero,et al. A slow-cycling Lgr5 tumour population mediates basal cell carcinoma relapse after therapy , 2018, Nature.
[103] F. Peale,et al. A cell identity switch allows residual BCC to survive Hedgehog pathway inhibition , 2018, Nature.
[104] Michael S. Goldberg,et al. Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice , 2018, Science.
[105] S. Sleijfer,et al. Pan-cancer whole-genome analyses of metastatic solid tumours , 2018, bioRxiv.
[106] Margaret P. Chapman,et al. Differentiation-state plasticity is a targetable resistance mechanism in basal-like breast cancer , 2018, Nature Communications.
[107] A. Schneeweiss,et al. Stress signaling in breast cancer cells induces matrix components that promote chemoresistant metastasis , 2018, EMBO molecular medicine.
[108] Maria C. Lecca,et al. Stem cell functionality is microenvironmentally defined during tumour expansion and therapy response in colon cancer , 2018, Nature Cell Biology.
[109] Zhong-hua Chu,et al. The mechanisms of colorectal cancer cell mesenchymal–epithelial transition induced by hepatocyte exosome-derived miR-203a-3p , 2018, Journal of Bio-X Research.
[110] H. Clevers,et al. Paneth Cells Respond to Inflammation and Contribute to Tissue Regeneration by Acquiring Stem-like Features through SCF/c-Kit Signaling. , 2018, Cell reports.
[111] K. Flaherty,et al. Toward Minimal Residual Disease-Directed Therapy in Melanoma , 2018, Cell.
[112] F. Rojo,et al. Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer , 2018, Nature Communications.
[113] M. Rosenblum,et al. Pericyte-like spreading by disseminated cancer cells activates YAP and MRTF for metastatic colonization , 2018, Nature Cell Biology.
[114] O. Klein,et al. Parasitic helminthes induce fetal-like reversion in the intestinal stem cell niche , 2018, Nature.
[115] E. Furth,et al. EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration. , 2018, Developmental cell.
[116] Johan Hartman,et al. Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing , 2018, Cell.
[117] T. Voet,et al. Identification of the tumour transition states occurring during EMT , 2018, Nature.
[118] P. Glazer,et al. The hypoxic tumor microenvironment in vivo selects the cancer stem cell fate of breast cancer cells , 2018, Breast Cancer Research.
[119] M. Shen,et al. Lineage Plasticity in Cancer Progression and Treatment. , 2018, Annual review of cancer biology.
[120] R. Sachidanandam,et al. Quiescent Tissue Stem Cells Evade Immune Surveillance , 2018, Immunity.
[121] E. Wagner,et al. Transcriptional regulation by NR5A2 links differentiation and inflammation in the pancreas , 2018, Nature.
[122] Camille Stephan-Otto Attolini,et al. TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis , 2018, Nature.
[123] H. Yao,et al. CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness , 2018, Cell.
[124] R. Bourgon,et al. TGF-β attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells , 2018, Nature.
[125] O. Nielsen,et al. YAP/TAZ-Dependent Reprogramming of Colonic Epithelium Links ECM Remodeling to Tissue Regeneration , 2018, Cell stem cell.
[126] Q. She,et al. Snail determines the therapeutic response to mTOR kinase inhibitors by transcriptional repression of 4E-BP1 , 2017, Nature Communications.
[127] A. Tsirigos,et al. TGF-β-Induced Quiescence Mediates Chemoresistance of Tumor-Propagating Cells in Squamous Cell Carcinoma. , 2017, Cell stem cell.
[128] Shawn M. Gillespie,et al. Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer , 2017, Cell.
[129] H. Clevers,et al. Cancer stem cells revisited , 2017, Nature Medicine.
[130] R. Kaplan,et al. KLF4-dependent perivascular cell plasticity mediates pre-metastatic niche formation and metastasis , 2017, Nature Medicine.
[131] Richard A. Moore,et al. Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy , 2017, Nature.
[132] P. Giresi,et al. Repression of Stress-Induced LINE-1 Expression Protects Cancer Cell Subpopulations from Lethal Drug Exposure. , 2017, Cancer cell.
[133] Jill P. Mesirov,et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway , 2017, Nature.
[134] Stuart L. Schreiber,et al. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition , 2017, Nature.
[135] J. Thiery,et al. New insights into the role of EMT in tumor immune escape , 2017, Molecular oncology.
[136] Sydney M. Shaffer,et al. Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance , 2017, Nature.
[137] E. Batlle,et al. A genome editing approach to study cancer stem cells in human tumors , 2017, EMBO molecular medicine.
[138] Francisco J. Sánchez-Rivera,et al. A Wnt-producing niche drives proliferative potential and progression in lung adenocarcinoma , 2017, Nature.
[139] Antonina V. Kurtova,et al. A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer , 2017, Nature.
[140] Shinya Sugimoto,et al. Visualization and targeting of LGR5+ human colon cancer stem cells , 2017, Nature.
[141] Thomas R. Cox,et al. Pre-metastatic niches: organ-specific homes for metastases , 2017, Nature Reviews Cancer.
[142] R. Weinberg,et al. Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells , 2017, Proceedings of the National Academy of Sciences.
[143] Shawn M. Gillespie,et al. Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance. , 2017, Cell stem cell.
[144] Michael R. Padgen,et al. Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments , 2017, Nature Cell Biology.
[145] Henry W. Long,et al. Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance , 2017, Science.
[146] M. Rubin,et al. SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer , 2017, Science.
[147] Rainer Spang,et al. Early dissemination seeds metastasis in breast cancer , 2016, Nature.
[148] Mariella G. Filbin,et al. Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma , 2016, Nature.
[149] Christian Frezza,et al. Tissue-specific and convergent metabolic transformation of cancer correlates with metastatic potential and patient survival , 2016, Nature Communications.
[150] X. Bian,et al. Cancer stem cells and their vascular niche: Do they benefit from each other? , 2016, Cancer letters.
[151] R. Kalluri. The biology and function of fibroblasts in cancer , 2016, Nature Reviews Cancer.
[152] Sridhar Ramaswamy,et al. HER2 expression identifies dynamic functional states within circulating breast cancer cells , 2016, Nature.
[153] N. Aceto,et al. Stem-like features of cancer cells on their way to metastasis , 2016, Biology Direct.
[154] C. Blanpain,et al. Cancer Stem Cells: Basic Concepts and Therapeutic Implications. , 2016, Annual review of pathology.
[155] I. Ng,et al. Cancer-Associated Fibroblasts Regulate Tumor-Initiating Cell Plasticity in Hepatocellular Carcinoma through c-Met/FRA1/HEY1 Signaling. , 2016, Cell reports.
[156] M. Shen,et al. Basal Progenitors Contribute to Repair of the Prostate Epithelium Following Induced Luminal Anoikis , 2016, Stem cell reports.
[157] Elisa de Stanchina,et al. Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT , 2016, Cell.
[158] L. Ferrucci,et al. sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance , 2016, Nature.
[159] Alexander van Oudenaarden,et al. Replacement of Lost Lgr5-Positive Stem Cells through Plasticity of Their Enterocyte-Lineage Daughters. , 2016, Cell stem cell.
[160] Marc J. Williams,et al. Identification of neutral tumor evolution across cancer types , 2016, Nature Genetics.
[161] M. Miyazaki,et al. Prrx1 isoform switching regulates pancreatic cancer invasion and metastatic colonization , 2016, Genes & development.
[162] S. Durinck,et al. Targeting PTPRK-RSPO3 colon tumours promotes differentiation and loss of stem-cell function , 2015, Nature.
[163] J. Theys,et al. Targeting Notch to overcome radiation resistance , 2015, Oncotarget.
[164] C. Nervi,et al. Epigenetic treatment of solid tumours: a review of clinical trials , 2015, Clinical Epigenetics.
[165] Erik Sahai,et al. Mesenchymal Cancer Cell-Stroma Crosstalk Promotes Niche Activation, Epithelial Reversion, and Metastatic Colonization , 2015, Cell reports.
[166] Yang Xie,et al. Phase 1 study of romidepsin plus erlotinib in advanced non-small cell lung cancer. , 2015, Lung cancer.
[167] J. Wrana,et al. Yap-dependent reprogramming of Lgr5+ stem cells drives intestinal regeneration and cancer , 2015, Nature.
[168] Jeong-Seok Nam,et al. Combinatorial TGF-β attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells , 2015, Oncotarget.
[169] Chih-Yang Wang,et al. Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells , 2015, Nature.
[170] R. Deberardinis,et al. Oxidative stress inhibits distant metastasis by human melanoma cells , 2015, Nature.
[171] Mehmet Toner,et al. En Route to Metastasis: Circulating Tumor Cell Clusters and Epithelial-to-Mesenchymal Transition. , 2015, Trends in cancer.
[172] May Yin Lee,et al. Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneity , 2015, Nature.
[173] Michael B. Stadler,et al. PIK3CAH1047R induces multipotency and multi-lineage mammary tumours , 2015, Nature.
[174] Michael Kahn,et al. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update , 2015, Nature Reviews Clinical Oncology.
[175] Hwa-Yong Lee,et al. Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype , 2015, Scientific Reports.
[176] Borja Saez,et al. Parent stem cells can serve as niches for their own daughter cells , 2015, Nature.
[177] Albert C. Chen,et al. Matrix stiffness drives Epithelial-Mesenchymal Transition and tumour metastasis through a TWIST1-G3BP2 mechanotransduction pathway , 2015, Nature Cell Biology.
[178] L. Borsu,et al. RAS mutations affect pattern of metastatic spread and increase propensity for brain metastasis in colorectal cancer , 2015, Cancer.
[179] Steffen Dickopf,et al. A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis , 2015, Nature.
[180] G. Getz,et al. RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer , 2015, Nature Communications.
[181] Z. Werb,et al. The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells? , 2015, Cell stem cell.
[182] Takanori Kanai,et al. Modeling colorectal cancer using CRISPR-Cas9–mediated engineering of human intestinal organoids , 2015, Nature Medicine.
[183] F. Dautry,et al. SMAD signaling and redox imbalance cooperate to induce prostate cancer cell dormancy , 2015, Cell cycle.
[184] Stephen T. C. Wong,et al. The osteogenic niche promotes early-stage bone colonization of disseminated breast cancer cells. , 2015, Cancer cell.
[185] M. Tan,et al. The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism. , 2015, Cancer letters.
[186] T. Welling,et al. Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells. , 2014, Gastroenterology.
[187] Ben S. Wittner,et al. Single-Cell RNA Sequencing Identifies Extracellular Matrix Gene Expression by Pancreatic Circulating Tumor Cells , 2014, Cell reports.
[188] S. Carr,et al. A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages , 2014, Nature Cell Biology.
[189] E. Fuchs,et al. Plasticity of epithelial stem cells in tissue regeneration , 2014, Science.
[190] S. Rorive,et al. SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma , 2014, Nature.
[191] J. Huse,et al. Osteopontin-CD44 signaling in the glioma perivascular niche enhances cancer stem cell phenotypes and promotes aggressive tumor growth. , 2014, Cell stem cell.
[192] A. Krešo,et al. Evolution of the cancer stem cell model. , 2014, Cell stem cell.
[193] Christopher J. Ott,et al. An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia , 2014, Nature Genetics.
[194] M. Kris,et al. Serpins Promote Cancer Cell Survival and Vascular Co-Option in Brain Metastasis , 2014, Cell.
[195] F. D. de Sauvage,et al. Lgr5+ stem cells are indispensable for radiation-induced intestinal regeneration. , 2014, Cell stem cell.
[196] M. Ittmann,et al. Prostatic inflammation enhances basal-to-luminal differentiation and accelerates initiation of prostate cancer with a basal cell origin , 2013, Proceedings of the National Academy of Sciences.
[197] F. Giancotti. Mechanisms Governing Metastatic Dormancy and Reactivation , 2013, Cell.
[198] P. Bragado,et al. TGFβ2 dictates disseminated tumour cell fate in target organs through TGFβ-RIII and p38α/β signalling , 2013, Nature Cell Biology.
[199] Panteleimon Rompolas,et al. Spatial organization within a niche as a determinant of stem cell fate , 2013, Nature.
[200] Berthold Göttgens,et al. The Epidermis Comprises Autonomous Compartments Maintained by Distinct Stem Cell Populations , 2013, Cell stem cell.
[201] Tim Holland-Letz,et al. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay , 2013, Nature Biotechnology.
[202] R. Russell,et al. Intestinal label-retaining cells are secretory precursors expressing Lgr5 , 2013, Nature.
[203] Sridhar Ramaswamy,et al. Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition , 2013, Science.
[204] H. Clevers,et al. Intestinal Tumorigenesis Initiated by Dedifferentiation and Acquisition of Stem-Cell-like Properties , 2013, Cell.
[205] M. Nieto,et al. Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. , 2012, Cancer cell.
[206] Jing Yang,et al. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. , 2012, Cancer cell.
[207] K. Jensen,et al. Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma. , 2012, Cancer cell.
[208] R. Kageyama,et al. Dclk1 distinguishes between tumor and normal stem cells in the intestine , 2012, Nature Genetics.
[209] C. Blanpain,et al. Multipotent and unipotent progenitors contribute to prostate postnatal development , 2012, Nature Cell Biology.
[210] G. Bell,et al. Critical role for lysyl oxidase in mesenchymal stem cell-driven breast cancer malignancy , 2012, Proceedings of the National Academy of Sciences.
[211] A. Oudenaarden,et al. Dll1+ secretory progenitor cells revert to stem cells upon crypt damage , 2012, Nature Cell Biology.
[212] Sylvain Brohée,et al. Distinct contribution of stem and progenitor cells to epidermal maintenance , 2012, Nature.
[213] Melanie A. Huntley,et al. Recurrent R-spondin fusions in colon cancer , 2012, Nature.
[214] Hans Clevers,et al. Lineage Tracing Reveals Lgr5+ Stem Cell Activity in Mouse Intestinal Adenomas , 2012, Science.
[215] Judith Campisi,et al. Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B , 2012, Nature Medicine.
[216] Benjamin D. Simons,et al. Defining the mode of tumour growth by clonal analysis , 2012, Nature.
[217] Tzong-Shiue Yu,et al. A restricted cell population propagates glioblastoma growth following chemotherapy , 2012, Nature.
[218] Jane Fridlyand,et al. Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors , 2012, Nature.
[219] T. Golub,et al. Tumor microenvironment induces innate RAF-inhibitor resistance through HGF secretion , 2012, Nature.
[220] K. Polyak,et al. Intra-tumour heterogeneity: a looking glass for cancer? , 2012, Nature Reviews Cancer.
[221] M. Ittmann,et al. Adult murine prostate basal and luminal cells are self-sustained lineages that can both serve as targets for prostate cancer initiation. , 2012, Cancer cell.
[222] A. Rocha,et al. Distinct stem cells contribute to mammary gland development and maintenance , 2011, Nature.
[223] P. Carmeliet,et al. A vascular niche and a VEGF–Nrp1 loop regulate the initiation and stemness of skin tumours , 2011, Nature.
[224] O. Klein,et al. A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable , 2011, Nature.
[225] D. Planchard,et al. Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer , 2011, British Journal of Cancer.
[226] Richard O Hynes,et al. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. , 2011, Cancer cell.
[227] Mauro Biffoni,et al. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells , 2011, Nature.
[228] Hideaki Tahara,et al. Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells , 2011, Proceedings of the National Academy of Sciences.
[229] Hans Clevers,et al. The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. , 2011, Cell stem cell.
[230] S. Pastorino,et al. Transdifferentiation of glioblastoma cells into vascular endothelial cells , 2011, Proceedings of the National Academy of Sciences.
[231] Rong Wang,et al. Glioblastoma stem-like cells give rise to tumour endothelium , 2010, Nature.
[232] A. Ashworth,et al. BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. , 2010, Cell stem cell.
[233] Alexander Roesch,et al. A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth , 2010, Cell.
[234] Louis Vermeulen,et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment , 2010, Nature Cell Biology.
[235] Ben S. Wittner,et al. A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations , 2010, Cell.
[236] N. Ferrara,et al. Autocrine VEGF Signaling Synergizes with EGFR in Tumor Cells to Promote Epithelial Cancer Development , 2010, Cell.
[237] M. Shen,et al. A luminal epithelial stem cell that is a cell of origin for prostate cancer , 2009, Nature.
[238] H. Clevers,et al. Single Lgr5 stem cells build cryptvillus structures in vitro without a mesenchymal niche , 2009, Nature.
[239] Andreas Trumpp,et al. IFNα activates dormant haematopoietic stem cells in vivo , 2009, Nature.
[240] Hans Clevers,et al. Lgr5 marks cycling, yet long-lived, hair follicle stem cells , 2008, Nature Genetics.
[241] S. Morrison,et al. Efficient tumor formation by single human melanoma cells , 2008, Nature.
[242] M. Todaro,et al. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity , 2008, Proceedings of the National Academy of Sciences.
[243] A. Puisieux,et al. Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition , 2008, PloS one.
[244] Wenjun Guo,et al. The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.
[245] Lloyd J. Old,et al. Adaptive immunity maintains occult cancer in an equilibrium state , 2007, Nature.
[246] H. Clevers,et al. Identification of stem cells in small intestine and colon by marker gene Lgr5 , 2007, Nature.
[247] C. Heeschen,et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. , 2007, Cell stem cell.
[248] Michael F. Clarke,et al. Phenotypic characterization of human colorectal cancer stem cells , 2007, Proceedings of the National Academy of Sciences.
[249] Benjamin D. Simons,et al. A single type of progenitor cell maintains normal epidermis , 2007, Nature.
[250] L. Ricci-Vitiani,et al. Identification and expansion of human colon-cancer-initiating cells , 2007, Nature.
[251] J. Dick,et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.
[252] S. Yamanaka,et al. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.
[253] Haiyan I. Li,et al. Purification and unique properties of mammary epithelial stem cells , 2006, Nature.
[254] François Vaillant,et al. Generation of a functional mammary gland from a single stem cell , 2006, Nature.
[255] Jane Q. Nguyen,et al. Stem cells in the hair follicle bulge contribute to wound repair but not to homeostasis of the epidermis , 2005, Nature Medicine.
[256] R. Henkelman,et al. Identification of human brain tumour initiating cells , 2004, Nature.
[257] Michael Karin,et al. IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer , 2004, Cell.
[258] S. Ramaswamy,et al. Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.
[259] E. Fuchs,et al. Defining the Epithelial Stem Cell Niche in Skin , 2004, Science.
[260] M. Rubin,et al. E-cadherin expression in primary carcinomas of the breast and its distant metastases , 2003, Breast Cancer Research.
[261] S. Morrison,et al. Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[262] M. Caligiuri,et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice , 1994, Nature.
[263] J. Gurdon,et al. The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles. , 1962, Journal of embryology and experimental morphology.
[264] H. Thé. Differentiation therapy revisited , 2018, Nature Reviews Cancer.
[265] Hushan Yang,et al. Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer , 2016, Breast Cancer Research and Treatment.
[266] D. Jaffe. In Vivo Lineage Tracing Defines the Role of Acinar-to-Ductal Transdifferentiation in Inflammatory Ductal Metaplasia , 2008 .
[267] Lars Holmgren,et al. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression , 1995, Nature Medicine.